Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about RHHBY
Recent news which mentions RHHBY
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
While Pfizer Faced A Setback, Altimmune, Roche And Mainz Biomed Advanced in The Battle Against Obesity And Colorectal Cancer
December 05, 2023
Tickers
ALT
MYNZ
PFE
RHHBY
Tags
contributors
Benzinga
General
From
Benzinga
Roche's Combination Therapy Shows Improved Progression Free Survival In Certain Breast Cancer With Mutation
December 05, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
Biotech
RHHBF
From
Benzinga
Jim Cramer Highlights 'Transformational' Impact Of Weight Loss Drugs Like Ozempic: Focus Now On 'Potential Winners' From The Same Narrative
December 04, 2023
Tickers
LLY
NVO
RHHBY
Tags
Market News
weight loss drugs
Jim Cramer
From
Benzinga
Roche Joins Bandwagon To Challenge Novo Nordisk, Eli Lilly For Weight Loss Drugs
December 04, 2023
Tickers
LLY
NVO
RHHBF
RHHBY
Tags
Biotech
Market News
RHHBF
From
Benzinga
AstraZeneca Strikes Deal With Absci To Leverage AI In Cancer Drug Discovery: Report
December 04, 2023
Tickers
ABSI
AZN
NVDA
RHHBY
Tags
Health Care
Contracts
RHHBY
From
Benzinga
Ignore Crypto: These Stocks Could Make You Rich
November 23, 2023
Tickers
MDT
NEE
RHHBY
Tags
MDT
Recent Press Releases
Market News
From
Motley Fool
Biotech Breakthroughs: 3 Revolutionary Stocks Redefining Healthcare
November 17, 2023
Tickers
CLDX
LUNG
PSTX
RHHBY
Tags
Stocks to Buy
PSTX
Market News
From
InvestorPlace
FDA Approves Bristol-Myers' Lung Cancer Drug Acquired Via $4B Turning Point Deal: Competes With Roche, Merck, AstraZeneca
November 16, 2023
Tickers
AZN
BMY
MRK
RHHBY
Tags
Media
Benzinga
Large Cap
From
Benzinga
The Alzheimer's Drug Market Is Heating Up. Should You Buy the Leading Contenders' Stocks?
November 10, 2023
Tickers
BIIB
LLY
RHHBY
Tags
Recent Press Releases
Market News
BIIB
From
Motley Fool
Regeneron's Skin Drugs Propel Revenue In Q3, Witnesses Strong Demand For Higher Dose Version Of Flagship Eye Drug
November 02, 2023
Tickers
REGN
RHHBY
Tags
why it's moving
REGN
Health Care
From
Benzinga
Sarepta/Roche's Closely Watched Duchenne Gene Therapy Faces More FDA Scrutiny - Stock Tanks
October 31, 2023
Tickers
RHHBF
RHHBY
RHHVF
SRPT
Tags
RHHBF
Market News
Biotech
From
Benzinga
Are Your Eyes At Grave Risk? FDA Issues Dangerous Warning Over Popular Drops From CVS, Target, Cardinal Health And More
October 28, 2023
Tickers
BHC
CAH
CVS
NVS
Tags
RADCQ
BHC
Benzinga
From
Benzinga
Roche, Lilly or Pfizer: Who's the Winner in IBD Wars?
October 28, 2023
Tickers
LLY
PFE
RHHBY
Tags
RHHBY
LLY
PFE
From
Motley Fool
It's Hard to Be a Biotech Bull in This Market, but This Stock Is a Buy
October 24, 2023
Tickers
PFE
RHHBY
ROIV
XBI
Tags
PFE
Recent Press Releases
Market News
From
Motley Fool
Why Is Roivant Sciences (ROIV) Stock Up Today?
October 23, 2023
Tickers
PFE
RHHBY
ROIV
Tags
NASDAQ:ROIV,OTCMKTS:RHHBY,NYSE:PFE
PFE
Market News
From
InvestorPlace
Roche Buys Pfizer & Roivant Sciences' Televant In ~$7.1B Deal
October 23, 2023
Tickers
PFE
RHHBF
RHHBY
ROIV
Tags
ROIV
Benzinga
News
From
Benzinga
Roivant, Pfizer shares rise as Roche agrees to buy immunology company for $7.1 billion
October 23, 2023
Tickers
PFE
RHHBY
ROIV
Tags
PFE
RHHBY
ROIV
From
MarketWatch
Which Is the Better Long-Term Hold for Investors: Pfizer or Roche?
October 21, 2023
Tickers
BMY
BNTX
PFE
REGN
Tags
REGN
PFE
Recent Press Releases
From
Motley Fool
PTC Therapeutics stock jumps on royalty deal worth up to $1.5 billion
October 19, 2023
Tickers
PTCT
RHHBY
RPRX
SPX
Tags
PTCT
RHHBY
RPRX
From
MarketWatch
Roche Reports Nine Months Sales Growth Despite Lower Sales From COVID-19 Products
October 19, 2023
Tickers
RHHBF
RHHBY
RHHVF
Tags
Market News
Biotech
RHHBF
From
Benzinga
What's Going On Cancer Player Monte Rosa Therapeutics Stock Today?
October 17, 2023
Tickers
GLUE
RHHBF
RHHBY
RHHVF
Tags
RHHBF
Market News
Biotech
From
Benzinga
FDA Approves Merck's Top Selling Drug, Keytruda For Expanded Use In Lung Cancer Indication
October 17, 2023
Tickers
AZN
BMY
MRK
RHHBY
Tags
Health Care
RHHBY
Briefs
From
Benzinga
Why Is Alzheimer's Player Prothena Stock Trading Higher Today?
October 16, 2023
Tickers
BMY
NVO
PRTA
RHHBY
Tags
Benzinga
Movers
General
From
Benzinga
Tempest Therapeutics shares head back to earth after 4,000% gain
October 12, 2023
Tickers
RHHBY
SPX
TPST
Tags
TPST
SPX
RHHBY
From
MarketWatch
TPST Stock: 7 Things to Know About Tempest Therapeutics
October 11, 2023
Tickers
RHHBY
TPST
Tags
NASDAQ:TPST,OTCMKTS:RHHBY
RHHBY
Today's Market
From
InvestorPlace
Is There A Blood Test for Alzheimer's? Progress Underway, But Not Quite Ready
October 11, 2023
Tickers
BIIB
DGX
ESALY
LH
Tags
Benzinga
ESALY
LH
From
Benzinga
Tempest Therapeutics’ stock jumps 1,900% as liver-cancer treatment shows promise
October 11, 2023
Tickers
RHHBY
SPX
TPST
Tags
TPST
SPX
RHHBY
From
MarketWatch
Tiziana Advances Phase 2 Site Selection For Its Lead Clinical Program In Non-Active Secondary Progressive Multiple Sclerosis (SPMS) And The Company Prepares For Six-Month Clinical Data Update
October 04, 2023
Tickers
RHHBY
SNY
TLSA
Tags
Market News
Partner Content
Biotech
From
Benzinga
Biotechnology Breakthroughs: 3 Biotech Stocks That Could Make Early Investors Rich
October 03, 2023
Tickers
CRSP
MRNA
PSTX
RHHBY
Tags
Market News
RHHBY
Stocks to Buy
From
InvestorPlace
2 Cathie Wood Stocks That Could Deliver Exponential Returns
October 02, 2023
Tickers
ARKK
EXAS
NVDA
RHHBY
Tags
RXRX
EXAS
ARKK
From
Motley Fool
< Previous
1
2
3
4
5
6
7
8
9
...
13
14
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.